Genmab reported DKK26.66B in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Amarin AMRN:US USD 587.83M 7.78M
Amgen AMGN:US USD 3.65B 1.23B
Artemis Alpha ATS:LN GBP 124.1M 35.06M
AstraZeneca AZN:LN USD 35.13B 798M
Bayer BAYN:GR EUR 41.27B 3.25B
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Exelixis EXEL:US USD 2.49B 100.14M
Fresenius Medical Care FME:GR EUR 16.74B 1.28B
Galapagos GLPG:NA EUR 2.69B 43.45M
Genmab GEN:DC DKK 26.66B 2.18B
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Hikma Pharmaceutical HIK:LN USD 2.18B 277M
Immunogen IMGN:US USD 178.01M 71.82M
Insmed INSM:US USD -29959000 74.2M
Lonza Group LONN:SW CHF 10.6B 586M
Merck MRK:GR EUR 28.26B 2.31B
Novartis NOVN:VX USD 60.82B 2.1B
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Roche Holding ROG:VX 25.19B 700M
Seattle Genetics SGEN:US USD 2.82B 111M
William Demant Holding WDH:DC DKK 8.18B 202M